These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33326128)

  • 1. L-lysine therapy to control the clinical evolution of pityriasis rosea: Clinical case report and literature review.
    Pedrazini MC; Groppo FC
    Dermatol Ther; 2021 Jan; 34(1):e14679. PubMed ID: 33326128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review.
    Pedrazini MC; da Silva MH
    Dermatol Ther; 2021 Nov; 34(6):e15129. PubMed ID: 34533265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of high-dose acyclovir in pityriasis rosea.
    Drago F; Vecchio F; Rebora A
    J Am Acad Dermatol; 2006 Jan; 54(1):82-5. PubMed ID: 16384760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gestational Pityriasis Rosea: Suggestions for Approaching Affected Pregnant Women.
    Monastirli A; Pasmatzi E; Badavanis G; Tsambaos D
    Acta Dermatovenerol Croat; 2016 Dec; 24(4):312-313. PubMed ID: 28128088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pityriasis Rosea: An Updated Review.
    Leung AKC; Lam JM; Leong KF; Hon KL
    Curr Pediatr Rev; 2021; 17(3):201-211. PubMed ID: 32964824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pityriasis Rosea after COVID-19 Infection.
    Prtajin M; Ljubojević Hadžavdić S
    Acta Dermatovenerol Croat; 2022 Dec; 30(4):265-266. PubMed ID: 36919396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pityriasis rosea during omalizumab treatment for chronic spontaneous urticaria.
    Vaccaro M; Marafioti I; Cannavò SP; Ciccarese G; Drago F
    Dermatol Ther; 2020 Nov; 33(6):e14356. PubMed ID: 33009684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent pityriasis rosea and Bell's palsy.
    Voss V; Mattox A; Guo M
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28115404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of human herpes virus 6 and 7 in the pathogenesis of pityriasis rosea.
    Yildirim M; Aridogan BC; Baysal V; Inaloz HS
    Int J Clin Pract; 2004 Feb; 58(2):119-21. PubMed ID: 15055857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent pityriasis rosea: an unusual form of pityriasis rosea with persistent active HHV-6 and HHV-7 infection.
    Drago F; Broccolo F; Ciccarese G; Rebora A; Parodi A
    Dermatology; 2015; 230(1):23-6. PubMed ID: 25612842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of pityriasis rosea with human herpesvirus-6 and human herpesvirus-7 in Taipei.
    Wong WR; Tsai CY; Shih SR; Chan HL
    J Formos Med Assoc; 2001 Jul; 100(7):478-83. PubMed ID: 11579614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological study of human herpesvirus-6 and human herpesvirus-7 in pityriasis rosea.
    Kosuge H; Tanaka-Taya K; Miyoshi H; Amo K; Harada R; Ebihara T; Kawahara Y; Yamanishi K; Nishikawa T
    Br J Dermatol; 2000 Oct; 143(4):795-8. PubMed ID: 11069458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symmetric blaschkoid pityriasis rosea in a child.
    Bhanja DB; Sil A; Chakraborty S; Panigrahi A; Punithakumar EJ
    Pediatr Dermatol; 2021 May; 38(3):701-703. PubMed ID: 33742484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of oral acyclovir during early course of pityriasis rosea: a systematic review and meta-analysis.
    Chang HC; Sung CW; Lin MH
    J Dermatolog Treat; 2019 May; 30(3):288-293. PubMed ID: 30109959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose of acyclovir may be an effective treatment against pityriasis rosea: a random investigator-blind clinical trial on 64 patients.
    Rassai S; Feily A; Sina N; Abtahian S
    J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):24-6. PubMed ID: 20477925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for pityriasis rosea.
    Contreras-Ruiz J; Peternel S; Jiménez Gutiérrez C; Culav-Koscak I; Reveiz L; Silbermann-Reynoso ML
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HHV 6-7 reactivation causing Pityriasis Rosea and labyrinthitis: A case report.
    El-Hussein M; El-Tawil C; Nakhle R; Souaiby N
    Am J Emerg Med; 2020 Sep; 38(9):1969.e1-1969.e3. PubMed ID: 32553563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyclovir is not effective in pityriasis rosea: Results of a randomized, triple-blind, placebo-controlled trial.
    Singh S; ; Tiwary NK
    Indian J Dermatol Venereol Leprol; 2016; 82(5):505-9. PubMed ID: 27212277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human herpesvirus 6 and 7 DNA in peripheral blood leucocytes and plasma in patients with pityriasis rosea by polymerase chain reaction: a prospective case control study.
    Chuh AA; Chiu SS; Peiris JS
    Acta Derm Venereol; 2001; 81(4):289-90. PubMed ID: 11720179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pityriasis Rosea: A Comprehensive Classification.
    Drago F; Ciccarese G; Rebora A; Broccolo F; Parodi A
    Dermatology; 2016; 232(4):431-7. PubMed ID: 27096928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.